Joan Elizabeth Miller

CIK 1410233 · SVP-Oncology & Neurology Srvcs · last filed 2012-03-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.57M

Companies

1

Total Filings

33

Lifetime Open-Market Net

-$16.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DGX SVP-Oncology & Neurology Srvcs 90,279 $227.90 $20.57M -$16.17M 33 2012-03-02

Recent Filings · Page 3 of 4

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-11-06 DGX Mixed -$330.5K EDGAR
2009-08-24 DGX Mixed −12,717 -$1.17M EDGAR
2009-08-18 DGX Sell (S) −5,514 -$302.2K EDGAR
2009-07-29 DGX Mixed -$726.7K EDGAR
2009-07-27 DGX Sell (S) −4,274 -$239.3K EDGAR
2009-03-11 DGX Mixed +2,249 -$56.2K EDGAR
2009-03-06 DGX Tax (F) −1,091 -$50.4K EDGAR
2009-02-26 DGX Sell (S) −10,000 -$511.0K EDGAR
2009-02-13 DGX Grant (A) +11,828 $0 EDGAR
2009-02-10 DGX Sell (S) −5,000 -$261.2K EDGAR
Showing 2130 of 33
Page 3 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.